Bär & Karrer Advises Sanofi on Exchange Transaction with Boehringer Ingelheim
Sanofi and Boehringer Ingelheim confirmed closing (in most markets) on 1 January 2017 of a $25 billion transaction involving the exchange of Sanofi’s animal health business and Boehringer Ingelheim’s consumer healthcare business.
Bär & Karrer acted as Swiss legal advisor to Sanofi. The team included Ralph Malacrida, Micha Schilling (both M&A), Mani Reinert (Competition), Markus Wang, and Raphael Nusser (both IP). Weil, Gotshal & Manges LLP acted as global lead counsel to Sanofi.